
Vivani Medical fell 21.0% from $1.43 to $1.13, behind the S&P 500's +9.8%. Its worst day was Jul 10 (−12.8%), and its low came Mar 30 at $0.94.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.11 beat the $-0.11 estimate on $0.00 revenue.
−11.4% · S&P 500 −1.7%
Vivani Medical shares rose 11.0%, while the S&P 500 rose 1.2%.
Story events cover the past 12 months · Times ET
+11.0% · S&P 500 +1.2%
Vivani Medical shares rose 10.9%, while the S&P 500 rose 1.0%.
+10.9% · S&P 500 +1.0%
EPS of $-0.09 beat the $-0.09 estimate on $0.00 revenue.
−5.6% · S&P 500 −1.7%
Vivani Medical shares rose 14.9%, while the S&P 500 rose 0.2%.
+14.9% · S&P 500 +0.2%
EPS of $-0.08 beat the $-0.08 estimate on $0.00 revenue.
+3.4% · S&P 500 +0.8%
Vivani Medical closed at its highest level of the year, 11.9% above where the year started.
+18.5%, the year's best day · S&P 500 −0.3%
EPS of $-0.07 beat the $-0.08 estimate on $0.00 revenue.
+4.5% · S&P 500 −0.2%
Where it ended: a close of $1.13 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 11, 2026 (EPS est. $-0.09).
Nothing in the past 12 months.
All VANI dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for VANI and SPY from Benzinga historical bars. Not investment advice.